Maynard Um
-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Hims and Hers (HIMS)
-
-
-
-
-
-
-
Hims & Hers responds to FTC lawsuit, says claims are "baseless"
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Raised to $37 at BofA Securities
-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Hims and Hers (HIMS)
-
-
-
-
-
-
-
Hims & Hers launches generic semaglutide in Canada at $149 monthly
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Raised to $35 at Needham
-
-
-
-
-
-
-
Hims & Hers Health, Inc. (HIMS) call put ratio 3.4 calls to 1 put with a focus on 1K contracts of January 105 calls into quarter results
-
445,675 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

